Press Releases :: Avalo Therapeutics, Inc. (AVTX)

May 27, 2025 10:05 am EDT

Avalo Therapeutics to Participate in Upcoming Investor Conferences

May 12, 2025 7:00 am EDT

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

Apr 30, 2025 7:00 am EDT

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

Mar 26, 2025 7:00 am EDT

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Mar 20, 2025 7:00 am EDT

Avalo Reports 2024 Financial Results and Recent Business Updates

Feb 24, 2025 7:00 am EST

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Feb 4, 2025 8:00 am EST

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

Jan 2, 2025 7:00 am EST

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

Nov 12, 2024 7:00 am EST

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Nov 11, 2024 7:00 am EST

Avalo Therapeutics to Present at Upcoming Investor Conferences